PPID may not shorten horses’ lives, but it raises care needs
Horses diagnosed with pituitary pars intermedia dysfunction, or PPID, don’t appear to have shorter life expectancies than similar horses without the condition, but they do experience more medical problems over time. That’s the key takeaway from a new retrospective case-control study discussed by AVMA’s Veterinary Vertex and covered by The Horse. Researchers reviewed records from 1996 to 2024 for 132 horses with PPID and 274 age-, breed-, and owner-matched controls in first-opinion practice, and found median age at euthanasia was 26 years in the PPID group versus 24 years in controls. PPID was independently associated with poor healing, dental disease, hyperinsulinemia-associated laminitis, and NSAID use. On the podcast, the authors said they designed the study to better reflect what primary-care equine veterinarians actually see, rather than the more severe referral-case populations that have shaped much of the earlier literature. (pubmed.ncbi.nlm.nih.gov, veterinaryvertex.buzzsprout.com)
Why it matters: For equine veterinarians, the study helps reframe conversations with pet parents around prognosis. PPID may not mean a shorter lifespan, but it does mean a higher burden of chronic care, especially around laminitis risk, dental monitoring, and wound healing. The owner-matched control design also helps account for differences in management style and willingness to pursue care, making the findings especially relevant to everyday ambulatory practice. That aligns with broader PPID management trends: earlier testing is becoming more common, and long-term pergolide treatment has been associated with sustained clinical improvement and better quality of life, even if it doesn’t clearly extend survival. Industry testing programs have also expanded, with Boehringer Ingelheim and Cornell reporting more than 50,000 horses tested through their seasonal PPID screening initiative since 2013. (pubmed.ncbi.nlm.nih.gov, veterinaryvertex.buzzsprout.com)
What to watch: Expect more attention on earlier detection, long-term management protocols, and how primary-care equine practices monitor comorbidities in older horses with PPID. The podcast discussion also raised the possibility of a surveillance effect: horses on daily treatment may be watched more closely, which could increase detection of smaller problems and help explain some of the higher recorded medical-event burden. (veterinaryvertex.buzzsprout.com)